Dr Doussou Touré arrives for work at Coléah Medical Centre. She washes her hands from a bucket set up in front of the building, proceeds to a screening area where her temperature is checked and recorded and only then enters the bustling facility that she supervises.
“Ebola is under control now, but we try to keep up the infection prevention and control systems that were put in place during the outbreak,” Dr Touré says, pointing to several sturdy, brightly-coloured bins, each one designated for the disposal of varying waste matter.
A vaccine is a preventive biological product for human use that prevents and controls the occurrence and prevalence of infectious diseases, so the demand for such products is relatively rigid. Due to suspected deaths stemming from vaccination and some companies' (such as Shenzhen Kangtai, Tiantan Biological and Dalian Hissen) production halts of some products because of their failure to pass new GMP certification, China's human vaccine lot release volume in 2014 declined by 2.4% year on year to 791 million doses.
Shipping and storing vaccines in a ‘cold chain’ in the tropical heat of many resource-limited countries – whereby the vaccine is kept at temperatures between 2°C to 8°C from the point of manufacture until reaching the recipient – is a tremendous challenge and a major cause of poor immunisation coverage rates.
Many vaccines, such as those for Hep A and B, HPV, MMR and rabies, need several booster doses to achieve maximal immunological protection. Booster doses add to the complexity of vaccine administration, especially when used in large vaccination campaigns in the developing world.
Yesterday [10 Nov 2013], we all witnessed the exit of a lion.
Over his 100-year-plus lifespan, James Harlan Steele was a true pioneer in Public Health and the rebirth of One Health. He was tenacious in his quest to enlarge the role of veterinary medicine in public health, emboldened by the conviction that any avenue that can benefit the health and well-being of people leads to a more progressive, rational and fair state of affairs for his community, country, and the world.
Rabies experts gathered at a news conference in Senegal's capital, Dakar, to discuss the growing mortality rate surrounding the disease. Around 24,000 people in Africa die after contracting rabies each year, and doctors believe expensive vaccines are at the root of this epidemic.
"This is the disease of the poorest of the poor who can't afford the vaccine," Hervé Bourhy, a doctor at France's Pasteur Institute, said at a news conference.